Article

Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS.

Laboratory of Molecular Microbiology, NIAID, NIH, 4 Center Drive, Bethesda, Maryland 20892, USA.
Journal of Virology (Impact Factor: 4.65). 07/2007; 81(11):5594-606. DOI: 10.1128/JVI.00202-07
Source: PubMed

ABSTRACT Simian immunodeficiency virus (SIV) infection of macaques and human immunodeficiency virus type 1 (HIV-1) infection of humans result in variable but generally fatal disease outcomes. Most SIV-infected macaques progress to AIDS over a period of 1 to 3 years, in the face of robust SIV-specific immune responses (conventional progressors [CP]). A small number of SIV-inoculated macaques mount transient immune responses and progress rapidly to AIDS (rapid progressors [RP]). We speculated that the underlying pathogenic mechanisms may differ between RP and CP macaques. We compared the pathological lesions, virus loads, and distribution of virus and target cells in SIVsmE660- or SIVsmE543-infected RP and CP rhesus macaques at terminal disease. RP macaques developed a wasting syndrome characterized by severe SIV enteropathy in the absence of opportunistic infections. In contrast, opportunistic infections were commonly observed in CP macaques. RP and CP macaques showed distinct patterns of CD4(+) T-cell depletion, with a selective loss of memory cells in RP macaques and a generalized (naive and memory) CD4 depletion in CP macaques. In situ hybridization demonstrated higher levels of virus expression in lymphoid tissues (P < 0.001) of RP macaques and a broader distribution to include many nonlymphoid tissues. Finally, SIV was preferentially expressed in macrophages in RP macaques whereas the primary target cells in CP macaques were T lymphocytes at end stage disease. These data suggest distinct pathogenic mechanisms leading to the deaths of these two groups of animals, with CP macaques being more representative of HIV-induced AIDS in humans.

Download full-text

Full-text

Available from: Meggan Czapiga, Jul 10, 2014
0 Followers
 · 
105 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper provides some experimental investigation on the influence of the surface roughness on the flashover performance of ceramics in vacuum. The test samples were prepared with four kinds of ceramics (99.9% Alumina) which were polished by four different SiC abrasives. The flashover performances of 20 kinds of test samples have been tested with an impulse voltage in vacuum. According to the experimental results, it was found that the roughness of the test sample was quite different among different ceramics although the same grinding procedure was used with the same abrasive. It was also found that the flashover performance was influenced by the surface roughness, and there is a trend that the samples with a lower surface roughness have a higher breakdown voltage.
    Electrical Insulation, 2004. Conference Record of the 2004 IEEE International Symposium on; 10/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A subset of simian immunodeficiency virus (SIV)-infected macaques progresses rapidly to disease with transient SIV-specific immune responses and high viral loads. Unique SIV variants with convergent Env mutations evolve in these rapid progressor (RP) macaques. To address the pathogenic significance of RP-specific variants, we generated infectious molecular clones from the terminal-phase plasma of an RP macaque. Inoculation of macaques with a representative clone, SIVsmH635FC, resulted in a persistent viremia, comparable to that produced by pathogenic SIVsmE543-3, and a chronic disease with progressive loss of CD4(+) T cells. However, SIVsmH635FC did not reproduce the rapid-disease phenomenon. Molecular analyses of viruses from these macaques revealed rapid reversion to the wild-type SIVsmE543-3 sequence at two RP-specific sites and slower reversion at another three sites. SIVsmH635FC infection was not sufficient to cause rapid progression even following coinoculation with SIVsmE543-3, despite acute depletion of memory CD4(+) T cells. SIVsmH635FC competed efficiently during primary infection in the coinoculated macaques, but SIVsmE543-3 predominated after the development of SIV-specific immune responses. These data suggest that the replication fitness of the RP variant was similar to that of SIVsmE543-3 in a naïve host; however, SIVsmH635FC was at a disadvantage following the development of SIV-specific immune responses. Consistent with these findings, neutralization assays revealed that SIVsmH635FC was highly sensitive to neutralization but that the parental SIVsmE543-3 strain was highly resistant. This study suggests that the evolution of RP-specific variants is the result of replication in a severely immunocompromised host, rather than the direct cause of rapid progression.
    Journal of Virology 10/2007; 81(17):8891-904. DOI:10.1128/JVI.00614-07 · 4.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ability of vaccines to induce immunity both in mucosal and systemic compartments may be required for prevention of HIV infection and AIDS. We compared DNA-MVA vaccination regimens adjuvanted by IL-12 DNA, administered intramuscularly and nasally or only nasally. Most of the vaccinated Rhesus macaques de-veloped mucosal and systemic humoral and cell-mediated SHIV-specific immune responses. Stimulation of mu-cosal anti-Env IgA responses was limited. After rectal challenge with SHIV 89.6P, all vaccinated and naive an-imals became infected. However, most of the vaccinated animals showed significant control of viremia and protection from CD4 T cell loss and AIDS progression compared to the control animals. The levels of CD4 and CD8 T cell virus-specific responses measured on the day of challenge correlated with the level of viremia control observed later during the chronic infection. Postchallenge viremia levels inversely correlated with the preservation of SHIV-specific CD4 /IL-2 and CD8 /TNF-T cells but not with CD4 /IFN-T cells mea-sured over time after challenge. We also found that during the early chronic infection SHIV vaccination per-mitted a more significant preservation of both naive and memory CD4 T cells compared to controls. In ad-dition, we observed a more significant and prolonged preservation of memory CD4 T cells after SHIV vaccination and challenge than that observed after SIV vaccination and challenge. As the antiviral immunity stimulated by vaccination is present in the memory CD4 T cell subpopulations, its more limited targeting by SHIV compared to SIV may explain the better control of X4 tropic SHIV than R5 tropic SIVs by vaccination.